Bensen Daniel's Form 4 filing
Tyra Biosciences, Inc. (TYRA) · filed Apr 3, 2023
- Accession no.
- 0001209191-23-022432
- Filed
- Apr 3, 2023
- Trade date
- Mar 30-Apr 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $70.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bensen DanielCIK 0001880946 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Common Stock | MOption exerciseAcquired | +2,000 | $0.61 | +$1,220 | 529,981 | Direct | |
| Mar 30, 2023 | Common Stock | SSaleDisposed | −2,000 | $16.01 | −$32,020 | 527,981 | Direct | |
| Mar 31, 2023 | Common Stock | MOption exerciseAcquired | +400 | $0.61 | +$244 | 528,381 | Direct | |
| Mar 31, 2023 | Common Stock | SSaleDisposed | −400 | $16.00 | −$6,400 | 527,981 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +2,000 | $0.61 | +$1,220 | 529,981 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −2,000 | $16.16 | −$32,320 | 527,981 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 231,821 | Direct | |
| Mar 31, 2023 | Common Stock | MOption exerciseDisposed | −400 | $0.00 | $0 | 231,421 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 229,421 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.